Literature DB >> 3387735

Application of 31P magnetic resonance spectroscopy to the study of athletic performance.

K K McCully1, J A Kent, B Chance.   

Abstract

Magnetic resonance spectroscopy is a non-invasive and repeatable method of studying muscle metabolism. Magnetic resonance spectroscopy uses specific radiofrequency pulses in a strong magnetic field to determine the relative concentrations of chemical compounds in the sample. 31P Magnetic resonance spectroscopy provides indirect measures of phosphate compounds such as adenosine triphosphate (ATP), phosphocreatine and inorganic phosphate. Muscle intracellular pH can also be determined. Exercise tests can be performed in the magnet such that the metabolic response to steady-state exercise can be measured. The ratio of inorganic phosphate to phosphocreatine reflects the relative metabolic rate of mitochondrial respiration (V) and the extrapolated maximum capacity of oxidative metabolism (Vm). Normal humans vary considerably in their metabolic response to exercise. These differences are reflected in their Vms and the degree of acidosis during exercise. Active muscles in endurance trained athletes have higher Vms and faster recovery rates than normal controls. Preliminary studies have been done to assess muscle glycolytic capacity by measuring the degree of acidosis during ischaemic exercise. Exercise-induced muscle injury can be detected as an increased inorganic phosphate to phosphocreatine ratio in resting muscle. The increase in the inorganic phosphate to phosphocreatine ratio with injury reaches a peak 1 to 2 days after the injury and lasts for up to a week. Similar increases in the inorganic phosphate to phosphocreatine ratio occur in patients with destructive neuromuscular diseases. Thus changes in the resting inorganic phosphate to phosphocreatine ratio may be used to detect the degree of muscle injury following exercise. Levels of H2PO4- in muscle are thought to be important in causing muscle fatigue during exercise. As 31P magnetic resonance spectroscopy can measure H2PO4-, magnetic resonance spectroscopy has become a useful technique in the study of the metabolic causes of muscle fatigue. It may also be possible to identify the relative populations of fast twitch and slow twitch fibres in a skeletal muscle using pH changes measured with 31P magnetic resonance spectroscopy. Magnetic resonance spectroscopy using other nuclei, such as 1H, 13C and 23Na, have the potential to provide information on other metabolic changes which occur with exercise. Magnetic resonance spectroscopy has shown promise as a technique to monitor the effects of training, including overtraining, in specific muscle groups in athletes.

Entities:  

Mesh:

Year:  1988        PMID: 3387735     DOI: 10.2165/00007256-198805050-00003

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  31 in total

1.  Creatine kinase equilibrium and lactate content compared with muscle pH in tissue samples obtained after isometric exercise.

Authors:  K Sahlin; R C Harris; E Hultman
Journal:  Biochem J       Date:  1975-11       Impact factor: 3.857

2.  Muscular fatigue investigated by phosphorus nuclear magnetic resonance.

Authors:  M J Dawson; D G Gadian; D R Wilkie
Journal:  Nature       Date:  1978-08-31       Impact factor: 49.962

3.  Magnetic resonance spectroscopy of the musculoskeletal system.

Authors:  C T Burt; J Koutcher; J T Roberts; R E London; B Chance
Journal:  Radiol Clin North Am       Date:  1986-06       Impact factor: 2.303

4.  Biochemical adaptations in muscle. Effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle.

Authors:  J O Holloszy
Journal:  J Biol Chem       Date:  1967-05-10       Impact factor: 5.157

5.  Phosphorus nuclear magnetic resonance of fast- and slow-twitch muscle.

Authors:  R A Meyer; T R Brown; M J Kushmerick
Journal:  Am J Physiol       Date:  1985-03

Review 6.  Standard anaerobic exercise tests.

Authors:  H Vandewalle; G Pérès; H Monod
Journal:  Sports Med       Date:  1987 Jul-Aug       Impact factor: 11.136

Review 7.  Mechanisms of exercise-induced delayed onset muscular soreness: a brief review.

Authors:  R B Armstrong
Journal:  Med Sci Sports Exerc       Date:  1984-12       Impact factor: 5.411

8.  31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle.

Authors:  S Eleff; N G Kennaway; N R Buist; V M Darley-Usmar; R A Capaldi; W J Bank; B Chance
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  High-energy phosphate compounds during exercise in human slow-twitch and fast-twitch muscle fibres.

Authors:  S Rehunen; H Näveri; K Kuoppasalmi; M Härkönen
Journal:  Scand J Clin Lab Invest       Date:  1982-10       Impact factor: 1.713

10.  The role of orthophosphate in crossbridge kinetics in chemically skinned rabbit psoas fibres as detected with sinusoidal and step length alterations.

Authors:  M Kawai
Journal:  J Muscle Res Cell Motil       Date:  1986-10       Impact factor: 2.698

View more
  4 in total

1.  A laboratory test for the examination of alactic running performance.

Authors:  Armin Kibele; David Behm
Journal:  J Sports Sci Med       Date:  2005-12-01       Impact factor: 2.988

2.  Standardisation of 31phosphorus-nuclear magnetic resonance spectroscopy determinations of high energy phosphates in humans.

Authors:  L Gariod; T Binzoni; G Ferretti; J F Le Bas; H Reutenauer; P Cerretelli
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1994

3.  Citrulline/malate promotes aerobic energy production in human exercising muscle.

Authors:  D Bendahan; J P Mattei; B Ghattas; S Confort-Gouny; M E Le Guern; P J Cozzone
Journal:  Br J Sports Med       Date:  2002-08       Impact factor: 13.800

Review 4.  Creatine in humans with special reference to creatine supplementation.

Authors:  P D Balsom; K Söderlund; B Ekblom
Journal:  Sports Med       Date:  1994-10       Impact factor: 11.136

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.